Editorial Comment from Dr Presicce et al. to Emerging links between non‐neurogenic lower urinary tract symptoms secondary to benign prostatic obstruction, metabolic syndrome and its components: A systematic review

Publisher： John Wiley & Sons Inc

E-ISSN： 1442-2042|22|11|992-992

ISSN： 0919-8172

Source： INTERNATIONAL JOURNAL OF UROLOGY, Vol.22, Iss.11, 2015-11, pp. : 992-992

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Response to Editorial Comment from Dr Cantiello and Dr Damiano to Emerging links between non‐neurogenic lower urinary tract symptoms secondary to benign prostatic obstruction, metabolic syndrome and its components: A systematic review

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 11, 2015-11 ,pp. : 993-993

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial Comment from Dr Cantiello and Dr Damiano to Emerging links between non‐neurogenic lower urinary tract symptoms secondary to benign prostatic obstruction, metabolic syndrome and its components: A systematic review

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 11, 2015-11 ,pp. : 991-991

John Wiley & Sons Inc

Access to resources Recommend Favorite

Emerging links between non‐neurogenic lower urinary tract symptoms secondary to benign prostatic obstruction, metabolic syndrome and its components: A systematic review

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 11, 2015-11 ,pp. : 982-990

John Wiley & Sons Inc

Access to resources Recommend Favorite

Individual patient data from registrational trials of silodosin in the treatment of non‐neurogenic male lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH): subgroup analyses of efficacy and safety data

By  

BJU INTERNATIONAL, Vol. 115, Iss. 5, 2015-05 ,pp. : 802-814

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial Comment from Dr Oh‐oka to Treatment satisfaction and clinically meaningful symptom improvement in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia: Secondary results from a 6‐month, randomized, double‐blind study comparing finasteride plus tadalafil with finasteride plus placebo

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 6, 2015-06 ,pp. : 588-588

John Wiley & Sons Inc

Access to resources Recommend Favorite